Skip to main navigation Skip to search Skip to main content

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.

Translated title of the contribution: Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.
  • M.H.J. van Oers
  • , R. Klasa
  • , R.E. Marcus
  • , M. Wolf
  • , E. Kimby
  • , R.D. Gascoyne
  • , A. Jack
  • , M.B. van 't Veer
  • , A. Vranovsky
  • , H. Holte
  • , M. van Glabbeke
  • , I. Teodorovic
  • , C. Roczewicz
  • , A. Hagenbeek

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contributionRituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.
Original languageUndefined/Unknown
Pages (from-to)3295-3301
Number of pages7
JournalBlood
Volume108
Issue number10
Publication statusPublished - 2006

Cite this